Suppr超能文献

棕榈油对心血管疾病风险的影响。

Effects of palm oil on cardiovascular risk.

作者信息

Chong Y H, Ng T K

机构信息

Palm Oil Research Institute of Malaysia, Kuala Lumpur.

出版信息

Med J Malaysia. 1991 Mar;46(1):41-50.

PMID:1836037
Abstract

A major public health concern of affluent nations is the excessive consumption of dietary fats which are now closely linked to coronary heart disease. Against this scenario, the tropical oils and palm oil in particular, have been cast as major villains in the U.S.A., despite the fact that palm oil consumption there is negligible. The unsuspecting public may not realise that the call to avoid palm oil is nothing more than a trade ploy since in recent years palm oil has been very competitive and has gained a major share of the world's edible oils and fats market. Many also lose sight of the fact that, palm oil, like other edible oils and fats, is an important component of the diet. The allegation that palm oil consumption leads to raised blood cholesterol levels and is therefore atherogenic is without scientific foundation. Examination of the chemical and fatty acid composition of palm oil or its liquid fraction should convince most nutritionists that the oil has little cholesterol-raising potential. The rationale for these are: it is considered cholesterol free. its major saturated fatty acid, palmitic acid (16:0) has recently been shown to be neutral in its cholesterolaemic effect, particularly in situations where the LDL receptors have not been down-regulated by dietary means or through a genetic effect. palm oil contains negligible amounts (less than 1.5%) of the hypercholesterolemic saturated fatty acids, namely lauric acid (12:0) and myristic acid (14:0). it has moderately rich amounts of the hypocholesterolaemic, monounsaturated oleic acid (18:1, omega-9) and adequate amounts of linoleic acid. (18:2, omega-6). It contains minor components such as the vitamin E tocotrienols which are not only powerful antioxidants but are also natural inhibitors of cholesterol synthesis. Feeding experiments in various animal species and humans also do not support the allegation that palm oil is atherogenic. On the contrary, palm oil consumption reduces blood cholesterol in comparison with the traditional sources of saturated fats such as coconut oil, dairy and animal fats. In addition, palm oil consumption may raise HDL levels and reduce platelet aggregability. As with all nutrients, there is a need to obtain a balance of different fatty acids found in fats in edible oils and other food sources. There is no single ideal source of fat that answers to the recent American Heart Association's call to reflect a 1:1:1 ratio of saturated, monounsaturated and polyunsaturated fats in relation to the recommended dietary fat intake of 30% of calories or less.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

富裕国家主要的公共卫生问题之一是膳食脂肪摄入过量,而这如今与冠心病密切相关。在这种背景下,热带油类,尤其是棕榈油,在美国被视为主要的“罪魁祸首”,尽管美国的棕榈油消费量微乎其微。毫无戒心的公众可能没有意识到,呼吁人们避免食用棕榈油不过是一种贸易策略,因为近年来棕榈油竞争力很强,已在全球食用油脂市场占据了很大份额。许多人也忽视了这样一个事实,即棕榈油与其他食用油脂一样,是饮食中的重要组成部分。声称食用棕榈油会导致血液胆固醇水平升高,因此具有致动脉粥样硬化性,这是没有科学依据的。对棕榈油或其液态部分的化学和脂肪酸组成进行研究,应该会让大多数营养学家相信,这种油几乎没有升高胆固醇的潜力。理由如下:它被认为不含胆固醇;其主要的饱和脂肪酸棕榈酸(16:0)最近被证明对胆固醇水平的影响是中性的,特别是在低密度脂蛋白受体没有因饮食方式或遗传效应而下调的情况下;棕榈油中含高胆固醇的饱和脂肪酸月桂酸(12:0)和肉豆蔻酸(14:0)的含量微乎其微(低于1.5%);它含有适量的降胆固醇单不饱和油酸(18:1,ω-9)和足够量的亚油酸(18:2,ω-6);它还含有少量成分,如维生素E生育三烯酚,这些成分不仅是强大的抗氧化剂,也是胆固醇合成的天然抑制剂。对各种动物和人类进行的喂养实验也不支持棕榈油具有致动脉粥样硬化性这一说法。相反,与传统的饱和脂肪来源,如椰子油、乳制品和动物脂肪相比,食用棕榈油会降低血液中的胆固醇。此外,食用棕榈油可能会提高高密度脂蛋白水平,并降低血小板聚集性。与所有营养素一样,需要在食用油和其他食物来源的脂肪中所含的不同脂肪酸之间取得平衡。没有单一的理想脂肪来源能满足美国心脏协会最近提出的要求,即饱和、单不饱和和多不饱和脂肪的比例要达到1:1:1,这一比例是相对于建议的膳食脂肪摄入量(占卡路里的30%或更少)而言的。(摘要截选至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验